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OAZ Uses Distinct DNA- and Protein-Binding
Zinc Fingers in Separate BMP-Smad
and Olf Signaling Pathways
Gene responses to the BMPs are mediated by Smad
transcription factors (Heldin et al., 1997; MassagueÂ ,
1998). Upon being phosphorylated on serine residues
by the BMP receptor complex, Smad1 or its close homo-
logs, Smads 5 and 8, move into the nucleus where they
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New York, New York 10021 of Smad proteinsÐSmad2 and Smad3Ðwhich lead to
different responses that sometimes antagonize those of
the BMPs.
The gene responses induced by BMP-activatedSummary
Smads depend on the tissue or cell type (Wozney et al.,
1988; Hogan, 1996; Mehler et al., 1997). However, it isWe have identified the 30-zinc finger protein OAZ as
not known how the BMP-activated Smads recognizea DNA-binding factor that associates with Smads in
specific target genes in a cell-dependent manner. Theresponse to BMP2, forming a complex that transcrip-
Smad N-terminal domain (or MH1 domain) can specifi-tionally activates the homeobox regulator of Xenopus
cally bind to the DNA sequence CAGAC (Dennler et al.,mesoderm and neural development, Xvent-2. OAZ
1998; Zawel et al., 1998), but this interaction is neithercontains a BMP signaling module formed by two clus-
of high affinity nor selective (Shi et al., 1998). The MH1ters of fingers that bind Smads and the Xvent-2 BMP
domain recognizes the CAGAC sequence through aresponse element, respectively. Previously implicated
structural element whose sequence is fully conservedas a transcriptional partner of Olf-1/EBF in olfactory
in all Smads regardless of whether they function in theepithelium and lymphocyte development in the rat,
BMP, TGFb, or activin pathways (Shi et al., 1998). Thus,OAZ fulfills this role through clusters of fingers that are
the intrinsic DNA-binding activity of Smads may notseparate from the BMP signaling module. The mutually
exclusive use of OAZ by the BMP-Smad and Olf path- specify the choice of target genes. The related protein
ways illustrates the dual role of a multi±zinc finger Smad4 participates with BMP-activated Smads in the
protein in signal transduction during development. assembly of transcriptional complexes (Lagna et al.,
1996; Hata et al., 1998). However, Smad4 is also a part-
ner of Smads in the activin and TGFb pathways. There-Introduction
fore, Smad4 is also unlikely to play a major role in provid-
ing target gene specificity to a Smad complex.Bone morphogenetic proteins (BMPs), the largest group
The Smads that function in the TGFb/activin pathwayswithin the transforming growth factor b (TGFb) super-
can achieve specific recognition of target genes by as-family of hormonally active factors, control such funda-
sociating with other DNA-binding cofactors. Smad2mental processes as mesoderm patterning, left-right
binds to the Xenopus Mix-2 promoter (Chen et al., 1996;asymmetry, neurogenesis, somite and skeletal develop-
Liu et al., 1997) and the mouse goosecoid promoter inment, limb patterning, and the development of the kid-
association with the winged-helix proteins Fast-1 andney, gut, lung, and teeth (Wozney et al., 1988; Hogan,
Fast-2 (LabbeÂ et al., 1998), respectively. In other cases,1996; Mehler et al., 1997). The BMPs exert these effects
by controlling the activity of a diverse group of genes, Smad2 and Smad3 are thought to bind to target promot-
including many homeobox genes that, in turn, deploy ers by contacting factors that are independently capable
specific programs of gene expression. In Xenopus, of DNA binding and transcriptional activation, such as
BMP signaling activates the homeobox genes Xvent-1, AP-1 (Zhang et al., 1998) or TFE3 (Hua et al., 1998).
Xvent-2, and Msx-1, which mediate mesoderm ventral- Whether any of these modes of target gene recogni-
ization and suppress neuralization (Gawantka et al., tion applies to BMP-activated Smads has remained un-
1995; Suzuki et al., 1997; Onichtchouk et al., 1998). In known. In work designed to address this question, we
the mouse, BMPs activate Tlx-2, which is required for have identified OAZ as a DNA-binding cofactor that as-
primitive streak formation (Tang et al., 1998), Dlx5, which sociates with Smad1 in response to BMP2, allowing
regulates dorsoventral patterning and osteogenesis (Mi- selective recognition of the BMP response element in
yama et al., 1999), and Msx-1, which is implicated in the Xvent-2 promoter. OAZ has a striking structure con-
tooth development (Peters and Balling, 1999). In Dro- sisting of 30 zinc fingers distributed in several groups.
sophila the BMP factor decapentaplegic activates the Remarkably, OAZ was previously implicated as a tran-
homeobox genes tinman, which regulates the induction scriptional partner of Olf-1/EBF in the development of
of visceral mesoderm, dorsal muscles, and the heart (Xu the olfactory epithelium and pre-B lymphocytes in the
et al., 1998; Frasch, 1995), and Ubx, which controls gut rat (Tsai and Reed, 1997; 1998). The BMP signaling mod-
morphogenesis (Panganiban et al., 1990). ule of OAZ is separate from the regions involved in the
Olf-1/EBF interaction. Thus, OAZ is a bifunctional part-
ner in two distinct pathways, providing a paradigm for§ To whom correspondence should be addressed (e-mail: j-massague
@ski.mskcc.org). the multifunctional nature of multi±zinc finger proteins.
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Results shown). Both products are closely related (98% amino
acid sequence identity in the human) to a rat protein
Defining a BMP Response Element in Xvent-2 termed Roaz (Rat Olf-1/EBF associated zinc finger) (Tsai
In the Xenopus early embryo, BMP signals activate and Reed, 1997). Roaz was previously identified as a
Xvent-2, which plays a key role in mesoderm ventraliza- functional partner of Olf-1/EBF, a transcription factor
tion and as a suppressor of neurogenesis (Onichtchouk implicated in the development of the olfactory epithe-
et al., 1996; Onichtchouk et al., 1998). An Xvent-2 pro- lium (Wang et al., 1993) and pre-B lymphocytes (Hagman
moter construct responds to BMP2 via Smad1 in Xeno- et al., 1993). The reported start codon of Roaz corre-
pus (Onichtchouk et al., 1998) and also in P19 murine sponds to a conserved methionine (Met58) in the human
embryonal cells (Chen et al., 1998) but not in other cell homolog. However, in both genes, this codon does not
lines that contain BMP receptors and Smad1 (see be- match the Kozak consensus and is not immediately pre-
low). Therefore, Xenopus embryos and P19 cells must ceded by stop codons. Roaz most likely represents the
contain an essential factor for Smad1 activation of rat homolog missing an N-terminal portion that includes
Xvent-2. To identify this factor, we first delineated the the first zinc finger. The rat, human, and Xenopus pro-
Xvent-2 cis-acting elements that confer responsiveness teins are henceforth referred to as rOAZ, hOAZ, and
to BMP2. Promoter analysis in P19 cells revealed that XOAZ, respectively.
the region between nucleotides 2243 to 2191 contains
a BMP2 response element (BRE) (Figure 1A). A construct Primary Structure, Expression Pattern, and Nuclear
BREx4-luc containing four copies of this element was Localization of OAZ
strongly activated by BMP2 (Figure 1A). This response The zinc finger motifs of hOAZ are distributed in six
was not induced by cell incubation with TGFb or trans- consecutive groups of 1, 7, 5, 7, 5, and 5 fingers, respec-
fection of an activated TGFb receptor construct (data tively (Figure 1E). The intervening regions lack recogniz-
not shown). able motifs except for a putative nuclear localization
Sequence analysis of two other Xvent-2 family mem- signal located between fingers 26 and 27 (Figure 1D).
bers, Xvent-1B and Xvent-2B, that respond to BMP2 Indeed, an epitope-tagged hOAZ construct expressed
(Rastegar et al., 1999) revealed a region of similarity to in COS-1 cells was mostly localized in the nucleus (Fig-
the Xvent-2 BRE. This region includes a Smad consen- ure 2A). A vector encoding a GAL4 DNA-binding domain
sus binding site (CAGAC box [Zawel et al., 1998]) fused to hOAZ did not activate a GAL4 reporter con-
and flanking segments of sequence identity (ªflanking struct in transfected cells, suggesting that OAZ does not
boxesº in Figure 1B). Mutation of the CAGAC box or the have intrinsic transactivating activity (data not shown).
39 flanking box in the Xvent-2 promoter inhibited the In Xenopus, OAZ transcripts are present before the
BMP2 response, whereas mutations in the 59 flanking midblastula transition (stages 2±9) and their levels in-
box or elsewhere in the BRE region did not (Figures 1A crease from the neurula stage (stage 13; Figure 2B).
and 1B). BMP signaling is first detectable at the midblastula tran-
Using a biotinylated double-stranded BRE oligonucle- sition (S. Faure and M. Whitman, personal communica-
otide to precipitate proteins from P19 cells, we deter- tion), which is also when Xvent-2 transcripts first appear
mined that the Xvent-2 BRE is a Smad-binding region. (Figure 2B). The XOAZ transcripts are ubiquitous in the
Extracts from BMP2-treated cells formed a BRE-binding embryo up until the late neurula stage (data not shown),
complex containing endogenous Smad4 (Figure 1C). at which point they become enriched in the anterior
Mutations in the Smad-binding box or in the 39 flanking neural tube (Figures 2Ca and 2Cb). At the tadpole stage,box abolished formation of this complex (Figure 1C),
XOAZ is expressed at high levels in the forebrain, mid-
demonstrating the importance of these elements for
brain and, histmus, more weakly in the hindbrain, but
binding of the BMP2-induced Smad complex.
not in the spinal cord or the cement gland. Lower levels
of expression are also detectable in the branchial archesCloning a BRE-Binding Factor
(Figures 2Cc±2Ce).We searched for Xvent-2 BRE-binding factors by
In adult human tissues, a 7.5 kb OAZ transcript wasscreening a Xenopus oocyte cDNA library fused to the
detected by Northern analysis in RNA from brain, lung,GAL4 transcriptional activation domain in a strain of
skeletal muscle, heart, pancreas, and kidney, but notSaccharomyces cerevisiae expressing HIS3 and lacZ
liver or placenta (Figure 2D). A 5.5 kb transcript wasunder the control of four copies of the Xvent-2 BRE.
also detected in heart and skeletal muscle (Figure 2D).One positive clone (Y1H clone) was obtained. The cDNA
Analysis of poly(A)1 RNA from additional human tissuesinsert in this clone comprises a 1005 bp ORF that lacks
revealed expression of OAZ in the aorta, ovary, pituitary,consensus start or stop codons, suggesting that this
small intestine, fetal brain, fetal kidney, and, within thecDNA encodes the BRE-binding region of a larger pro-
adult brain, in the substantia nigra, medulla, amygdala,tein. A GenBank search uncovered a human homolog rep-
thalamus, and cerebellum (data not shown).resented by two partially overlapping ESTs (KIAA0760 [Na-
gase et al., 1998] and EST 2019478) from brain. These
OAZ as a Mediator of the Xvent-2 ResponseESTs jointly encode an ORF that starts with a Kozak
to BMPconsensus translation start site preceded by stop co-
Based on the sequence of an EST encoding mouse OAZdons. This ORF encodes a 1224 amino acid protein
(100% amino acid sequence identity to the hOAZ regioncomprising 30 KruÈ ppel zinc fingers (Figures 1D and 1E).
comprising residues 824±867), we detected by RT-PCRThe Xenopus Y1H product is highly homologous (89%
OAZ expression in P19 embryonic carcinoma cells andamino acid sequence identity) to fingers 6±13 of this
C3H10T1/2 (10T1/2) embryonic mesenchymal cells, buthuman homolog, with the linker regions between fingers
being as conserved as the fingers themselves (data not not in C2C12 myoblasts (Figure 3A). BMP2 stimulation
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Figure 1. The BMP Response Element of the Xenopus Vent-2 Gene
(A) 59 deletions and point mutations of Xenopus Vent-2 promoter-luciferase reporter constructs. P19 cells were transfected with the reporter
constructs and treated with or without 1 nM BMP2 for 18 hr prior to lysis and analysis for luciferase activity. The point mutations introduced
in the BMP responsive element (CAGAC mut, CAGAA mut, 59 box mut, 39 box mut1, and 39 box mut2) are shown in (B).
(B) The promoter regions of the Vent-1B and Vent-2B genes contain sequences similar to the BMP responsive element (BRE) of Vent-2. The
silent mutations are indicated in parentheses.
(C) Binding of a BMP2-induced endogenous Smad complex to the BRE. Extracts from BMP2-treated P19 cells were incubated with biotinylated
double-stranded oligonucleotides corresponding to the BRE (wild-type sequence, CAGAC, or 39 box mutants) and with streptavidin-agarose
beads. The precipitated complexes were subjected to Smad4 Western immunoblotting analysis.
(D) Human OAZ contains 30 KruÈ ppel-type zinc fingers (underlined) and a putative nuclear localization signal (double underline).
(E) Schematic structure of OAZ. Zinc fingers are indicated as closed boxes. The region corresponding to the XOAZ fragment cloned by yeast
one-hybrid screening is indicated.
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Figure 2. Subcellular Localization and Tissue
Distribution of OAZ
(A) OAZ is a nuclear protein. COS-1 cells
transfected with Flag-tagged OAZ were ana-
lyzed by indirect immunofluorescence using
a Flag monoclonal antibody. DAPI staining of
DNA is shown for comparison.
(B) Temporal expression of OAZ during Xeno-
pus development. RNA isolated from em-
bryos (stages 2±24) was subjected to RT-PCR
using primers to XOAZ, Xvent-2, and ODC
(as a loading control). PCR products were
visualized by autoradiography.
(C) In situ hybridization of XOAZ in Xenopus
embryos. At the late neurula stages (a and b),
XOAZ expression become restricted to the
anterior neural tube. At the tadpole stage
(c±e), XOAZ is expressed at high levels in the
forebrain, midbrain, and hindbrain, but not in
the spinal cord or the cement gland.
(D) Tissue distribution. OAZ mRNA in human
tissues.
activated the Xvent-2 reporter in P19 and 10T1/2 cells, but OAZ as a Functional Partner of Smads
in the BMP Pathwaynot in C2C12 cells, even though these cells have other
BMP2 responses (Katagiri et al., 1994) (Figure 3B). Co- A limited amount of hOAZ vector was transfected into
P19 cells so that this vector alone induced a minimaltransfection of a hOAZ vector increased the Xvent-2
reporter response in P19 and 10T1/2 and conferred re- (2-fold) enhancement of the Xvent-2 reporter response
to BMP2 (Figure 4A). Cotransfection of Smad1 andsponsiveness to C2C12 cells (Figure 3B). This response
was weaker in 10T1/2 and C2C12 cells than in P19 cells, Smad4 vectors under these conditions significantly po-
tentiated the OAZ-dependent effect of BMP2 (Figuresuggesting that other components of the BMP pathway
that activates this reporter are limiting in 10T1/2 4A). Cotransfection of OAZ with Smad2 and Smad4 vec-
tors did not confer responsiveness to either BMP2 orand C2C12 cells. Transfection of hOAZ in P19 cells
also increased the BMP2-dependent activation of the TGFb (Figure 4A), even though Smad2 in COS-1 cells is
reponsive to TGFb (Hata et al., 1997). In COS-1 cellsBREx4-luc construct (data not shown). OAZ had no ef-
fect on Xvent-2 reporter constructs containing muta- cotransfected with vectors encoding Smad1, Smad4,
and Flag epitope±tagged OAZ, BMP2 induced the asso-tions in the CAGAC box or in the 39 flanking box (Figure
3C). Thus, OAZ is required for BMP activation of the ciation of OAZ with the two Smad proteins (Figure 4B).
In contrast, TGFb did not induce an association ofXvent-2 reporter and has the same BRE sequence re-
quirements as the activation of this reporter by endoge- Smad2 or Smad4 with OAZ (Figure 4B). BMP2 also in-
duced an association between Flag-OAZ and endoge-nous factors (refer to Figure 1A) or the binding of an endog-
enous Smad complex to the BRE (refer to Figure 1C). nous Smad1 and Smad4 in both P19 cells (Figure 4C)
and COS-1 cells (data not shown). Thus, OAZ specifi-Tlx-2 is a BMP2 responsive gene, and its activation
is mediated by Smad1 (Macias-Silva et al., 1998). The cally cooperates with BMP-activated Smads.
Robust binding of OAZ, Smad1, and Smad4 to theBMP responsive region of Tlx2 does not contain se-
quence similarity to the BREs of the Xvent genes (data BRE was observed in extract from cells overexpressing
all three proteins and was dependent on cell stimulationnot shown). Overexpression of OAZ did not increase the
activation of a Tlx-2 reporter by BMP2 in P19 cells (Fig- with BMP2 (Figure 4D). BRE oligonucleotides with muta-
tions in the CAGAC box or in the 39 flanking box did noture 3D). In fact, OAZ overexpression inhibited this re-
sponse, raising the possibility that OAZ and a Tlx-2- precipitate this complex (Figures 4D). Separately, OAZ
and the Smads yielded only a low level of binding to theactivating Smad partner compete for a limited supply
of BMP-activated Smads in the cell. Thus, the role of BRE. Taken together, these results suggest that BMP2
induces the association of OAZ with Smad1 and Smad4,OAZ as a mediator of BMP2 gene responses appears
to be restricted to a subset of BMP2 target genes that which then synergistically bind to the BRE and activate
the Xvent-2 promoter.include Xvent-2 but not Tlx-2.
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Figure 3. OAZ Mediates Induction of the
Xvent-2 Gene by BMP2
(A) OAZ expression in mouse embryo cell
lines. RNA from P19, C2C12, and C3H10T1/2
(10T1/2) cells was subjected to RT-PCR using
primers to mOAZ and HPRT (as a loading
control). PCR products were visualized by au-
toradiography.
(B) OAZ expression confers Xvent-2 respon-
siveness to BMP2. Cells were transiently
transfected with the Xvent-2 reporter (2380/
21-luc) with or without hOAZ expression
plasmid (500 ng/well). Cells were treated
(black bars) or untreated (open bars) with 1
nM BMP2 for 18 hr prior to lysis and then
analyzed for luciferase activity.
(C) BRE requirements for activation by OAZ.
P19 cells were transfected with wild-type
(2245/21-luc) or mutant Xvent-2 reporter
(CAGAC box mutant and 39 box mutant) with
increasing amount of hOAZ expression plas-
mid (125, 250, and 500 ng/ml), and then as-
sayed as in (B).
(D) OAZ is specific for a subset of BMP target
genes. Reporter constructs containing pro-
moter regions of Xenopus Vent-2 and mouse
Tlx2 genes were transfected into P19 cells
with increasing amount of hOAZ vector (125,
250, and 500 ng/well), and then assayed as
in (B).
Interacting Regions contacts with the DNA (ZF-9-13mut construct) inacti-
vated OAZ (Figure 5D). Taken together, these resultsBRE-Binding Region in OAZ
A BRE-binding assay in yeast using lacZ as a reporter indicate that fingers 9±13 constitute the BRE-binding
region of OAZ (Figure 5A).confirmed that zinc fingers 6±13 of hOAZ (ZF6-13 con-
struct) binds directly to the BRE (Figure 5B). Interest- Smad-Interacting Region in OAZ
Using Flag epitope±tagged hOAZ constructs in trans-ingly, ZF6-13 is more active than full-length hOAZ in
this assay. Furthermore, ZF6-13 from COS-1 cell lysates fected COS-1 cells, we determined that the full-length
OAZ and its C-terminal half (ZF14-30) interacted withbinds to the BRE independently of cell stimulation with
BMP2 (Figure 5C) or Smads cotransfection (data not endogenous Smad4 in a BMP2-dependent manner,
whereas the BRE-interacting construct ZF6-13 did notshown). In the full-length OAZ, the BRE-binding region
may be occluded in the basal state and require BMP2- (Figure 5E). Further analysis using this assay showed
that the Smad-interacting region of OAZ maps to zincdependent association with Smads to become active.
Removal of the N-terminal 8 zinc fingers did not alter fingers 14±19 (Figures 5A and 5C).
Minimal BMP Signaling Module in OAZthe ability of hOAZ to enhance the Xvent-2 response to
BMP2 (Figure 5D). Removal of the 11 N-terminal fingers The constructs ZF1-25 and ZF1-19, which lack the Olf-
1/EBF binding region (Figure 5A), retained the ability topartially decreased this response, and removal of the
13 N-terminal fingers abolished it (Figure 5D, ZF12-30 enhance the Xvent-2 response to BMP2 (Figure 5D),
suggesting that this function of OAZ does not requireand ZF14-30). In other multi±zinc finger proteins, the
primary DNA contacts are established by at most four interaction with Olf-1/EBF. Flag immunofluorescence
analysis of the C-terminally truncated OAZ constructsfingers through a limited set of amino acid residues
(Pavletich, 1991; 1993) Alanine mutation of those resi- in transfected cells revealed an incomplete accumula-
tion of these constructs in the nucleus (data not shown).dues in fingers 9±13 that are most likely to make base
Cell
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Figure 4. OAZ Is a DNA-Binding Partner of
Smad1 and Smad4
(A) OAZ, Smad4, and Smad1, but not Smad2,
synergize in the activation of the Xvent-2 pro-
moter. P19 cells were transfected with hOAZ
alone (125 ng/well) or together with Smads
expression plasmids (1 mg/well) and Xvent-2
reporter (BREx4-luc). Cells were untreated
(open bars), treated with 1 nM BMP2 (black
bars), or 100 pM TGFb (hatched bars) for 18
hr prior to luciferase assay.
(B) OAZ forms a complex with Smad1 and
Smad4 upon BMP2 stimulation. Flag-tagged
hOAZ, full-length Smad1 or Smad2, and
Smad4 expression constructs were trans-
fected into COS-1 cells. BMP2 (1 nM) or TGFb
(100 pM) was added for 1 hr prior to lysis
as indicated. Interactions were analyzed by
immunoblotting of Flag immunoprecipitates
using Smad1-, Smad2-, and Smad4-specific
antisera. Expression of transfected products
was monitored by direct immunoblotting of
total cell lysates.
(C) Endogenous Smad1 and Smad4 interacts
with OAZ. A Flag-tagged hOAZ expression
construct was transfected into P19 cells.
BMP2 (1 nM) was added for 1 hr prior to lysis
as indicated. The interaction between OAZ
and endogenous Smad1 and Smad4 was an-
alyzed by immunoblotting of Flag immuno-
precipitates using a Smad1-specific or a
Smad4-specific antiserum. Expression of
OAZ was monitored by immunoblotting with
an anti-Flag antibody.
(D) Cooperative binding of OAZ and Smads
on the BRE. COS-1 cells were transfected
with Flag-tagged hOAZ, Smad1, and Smad4
expression constructs as indicated. Cells
were treated with or without BMP2 (1 nM) for
1 hr and lysed. Cell lysates were precipitated
with biotinylated BRE oligonucleotides with
or without mutations followed by analysis
of these complexes using anti-Flag, anti-
Smad1, and anti-Smad4 antibodies.
However, ZF9-19, which includes only the BRE- and 5C) but not with Smads (Figure 5A). Therefore, ZF1-13
Smad-interacting regions, was still able to mediate a may inhibit Xvent-2 activation by occluding the BRE. In
BMP2 response (Figure 5D), suggesting that those two contrast, ZF14-30 interacts with Smads (Figure 5A) but
regions together constitute a BMP signaling module that not with the BRE (Figure 5C). Therefore, ZF14-30 may
is necessary and sufficient for Xvent-2 promoter acti- inhibit Xvent-2 activation by sequestering endogenous
vation. Smads. We used ZF1-13 and ZF14-30 as dominant-
OAZ-Interacting Domains in Smad negative constructs to assess the role of endogenous
In transfected COS-1 cells, OAZ interacts with the MH2 factors in the activation of BMP-responsive genes in
domains of Smad1 or Smad4 but not their MH1 domains Xenopus.
or the Smad2 MH2 domain (Figure 5F). As purified GST A block in BMP signaling induces dorsalization of ven-
fusion proteins, the Smad1 MH2 domain bound to ZF9- tral mesoderm and neuralization of ectoderm in Xenopus
19, but the Smad2 or Smad4 MH2 domains did not (Hemmati-Brivanlou and Melton, 1997), and the same
(Figure 5G). Thus, the interaction of OAZ with Smad1 is effects are seen by interfering with the function of
direct and via the MH2 domain. The observed interaction Xvent-1 and Xvent-2 (Onichtchouk et al., 1998). Xvent-1
of OAZ with Smad4 in COS-1 cells (Figure 5F) may be and Xvent-2 are normally absent from the dorsal mar-
indirect via endogenous Smad1. ginal zone (DMZ) of gastrulae but are expressed in the
ventral marginal zone (VMZ) ([Onichtchouk et al., 1996;
1998] Figure 6B). Injection of ZF1-13 transcripts into theRole of OAZ in the Activation of Endogenous
VMZ reduced the expression of Xvent-1 and Xvent-2Xvent-1 and Xvent-2
(Figure 6B). At the tadpole stage, VMZ explants injectedOverexpression of ZF1-13 or ZF14-30 decreased the
with dominant-negative OAZ were partially dorsalized,Xvent-2 reporter response in P19 cells, and this effect
as shown by the decrease of a ventral mesoderm markerwas reversed by cotransfection of a wild-type hOAZ
vector (Figure 6A). ZF1-13 interacts with the BRE (Figure (globin) and the induction of the dorsolateral marker
Smad Cofactor in BMP Signaling
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Figure 5. Mapping of a Region of OAZ That Is Essential for BMP Signaling
(A) OAZ and its deletion mutants are shown schematically. The region of Xenopus OAZ cloned by BRE interaction in yeast, a putative nuclear
localization signal, and the regions reported to interact with DNA (TGGAGC) and Olf-1/EBF (Tsai and Reed, 1997) are indicated. The ability
of all these constructs to activate the Xvent-2 promoter (see panel D) and the ability of relevant constructs to interact with endogenous Smad4
(see panel E) are summarized.
(B) Direct binding of OAZ to the BMP-responsive element. hOAZ constructs fused to GAL4 transcriptional activation domain were transformed
into a yeast strain bearing a tetramerized BRE sequence upstream of lacZ. Interactions between BRE and hOAZ constructs were tested by
measuring b-galactosidase activity in solution.
(C) ZF6-13 interacts with BRE in a BMP2-independent manner. Flag-tagged hOAZ constructs were transiently transfected into COS-1 cells
with Smad1 and Smad4 expression constructs. Cell lysates were precipitated with biotinylated BRE oligonucleotides followed by immunoblot-
ting using anti-Flag antibody. Expression of constructs was monitored by direct anti-Flag immunoblotting.
(D) Mapping of the region of OAZ required for the activation of Xvent-2 promoter by BMP2. P19 cells were transfected with the Xvent-2
reporter (-245/-1-luc) together with increasing amounts of the hOAZ mutants shown in (A) (125 and 250 ng/well), treated (black bars) or
untreated (open bars) with BMP2 (1 nM) for 18 hr prior to luciferase assay. The level of induction of the luciferase activity by BMP2 is indicated
as Xvent-2 activation in (A).
(E) OAZ regions required for Smads binding. hOAZ constructs were transiently transfected into P19 cells, treated with 1 nM BMP2 for 1 hr,
and lysed. Cell lysates were subjected to immunoprecipitation of OAZ by anti-Flag antibody followed by immunoblotting using Smad4-specific
antisera.
(F) OAZ interacts with the MH2 domain of Smads. COS-1 cells were transfected with the Flag-tagged hOAZ construct together with the
untagged full-length version. The HA-tagged MH1 domain, or the untagged MH2 domain of Smad1, Smad2, and Smad4. Cells were treated
with or without BMP2 (1 nM) for 1 hr and lysed. Cell lysates were precipitated with anti-Flag antibody followed by immunoblotting using anti-
Smad1, anti-Smad2, and anti-Smad4 antibodies (full-length and MH2 domain constructs) or anti-HA antibody (MH1 domain constructs).
Expression of transfected DNA was monitored by direct immunoblotting using anti-HA, anti-Smad1, and anti-Smad4 antibodies. The nonspecific
band in the bottom panels corresponds to Ig heavy chain.
(G) Direct interaction of OAZ with the MH2 domain of Smad1. Bacterially expressed Flag-tagged ZF9-19 was incubated with Smad MH2
domains as sepharose-bound GST fusions. Bound material was separated by SDS-PAGE and visualized by anti-Flag immunoblotting (left
panel). Bacterially expressed protein purity and concentration were determined by Coomassie staining of aliquots (right panel).
muscle actin. Both at early and late developmental rescue could be explained by an ability of Smad1 to
increase the BRE-binding affinity of endogenous OAZstages, the effects of dominant-negative OAZ could be
reversed by coinjection of Smad1 RNA (Figure 6B). This but not that of the exogenous ZF1-13 (refer to Figure 5C).
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coexpression of either ZF1-13 or ZF14-30 (Figure 6C).
Injection of ZF-1-13 transcripts into the animal pole of
two-cell stage embryos inhibited the induction of globin
by coinjected BMP2 transcripts but did not inhibit the
induction of muscle actin by coinjected activin tran-
scripts (Figure 6D). The ability of the dominant-negative
OAZ constructs to reduce Xvent-1 and Xvent-2 ex-
pressionÐspecifically, by blocking BMP2 and Smad1
responsesÐthus inducing ectoderm neuralization and
ventral mesoderm dorsalization, indicates a role of en-
dogenous XOAZ or a closely related factor in the activa-
tion of these BMP target genes in Xenopus embryos.
OAZ as a Bifunctional Partner of Smads
and Olf-1/EBF
rOAZ binds Olf-1/EBF via the three C-terminal zinc fin-
gers (Tsai and Reed, 1997). Our results indicate that this
region is dispensable for BMP signaling (refer to Figure
5A). However, overexpression of Olf-1/EBF inhibited, in
a concentration-dependent manner, the ability of wild-
type hOAZ to mediate Xvent-2 promoter activation by
BMP2 (Figure 7A). Olf-1/EBF had no effect on the BMP-
signaling activity of ZF9-19, which lacks the Olf-1/EBF
interacting region (Figure 7A), suggesting Olf-1/EBF in-
terferes with the BMP-signaling activity of OAZ by bind-
ing to it.
In concert with Olf-1/EBF, OAZ can bind to, and acti-
vate transcription from Sp1 sites (Tsai and Reed, 1997).
This activity resides in the N-terminal seven-finger clus-
ter of OAZ (Tsai and Reed, 1997). hOAZ mimicked the
ability of rOAZ to activate transcription from the Sp1
Figure 6. Dominant-Negative OAZ Blocks BMP Signaling in Xeno- sites of the SV40 early promoter in concert with Olf-1/
pus Embryos
EBF (Tsai and Reed, 1997) (Figure 7B). Cotransfection
(A) ZF1-13 and 14-30 act as dominant-negative mutants. Wild-type
of Smad1 and Smad4, but not of Smad2 and Smad4,hOAZ and the ZF1-13 and ZF14-30 constructs were tested in the
partially inhibited this effect in the presence of BMP2Xvent-2 reporter assay as described in Figure 6B. Inhibition of
(Figure 7B). Thus, the ability of OAZ to act as a transcrip-Xvent-2 reporter by ZF1-13 and ZF14-30 was rescued by overex-
pression of wild-type OAZ (500 and 1000 ng/well). tional partner of Olf-1/EBF can be inhibited by BMP2 in
(B) Dominant-negative OAZ dorsalizes Xenopus mesoderm. mRNA a Smad-dependent manner. Collectively, these results
encoding ZF1-13 (5 ng) was injected alone or together with Smad1 suggest that OAZ acts as a partner of Olf-1/EBF and
transcripts into the ventral vegetal blastomeres of eight-cell stage
BMP Smads in transcriptional activation from distinctembryos. Total RNA collected from gastrula and tadpole stage em-
DNA sites. As schematically summarized in Figure 7C,bryos was subjected to RT-PCR in order to measure the expression
Smads and Olf-1/EBF appear to act antagonistically inof the ventral markers Xvent-1 and Xvent-2 and globin, and the
dorsolateral marker muscle actin. Histone is used as a loading their ability to share OAZ as a DNA-binding partner.
control.
(C) Dominant-negative OAZ inhibits Smad1 function and neuralizes
Xenopus ectoderm. ZF1-13 or ZF14-30 transcripts (5 ng) were in-
Discussionjected alone or together with Smad1 mRNA (1 ng) into the animal
pole of two-cell stage embryos. At the blastula stage, animal caps
The Smad proteins mediate many of the gene responseswere dissected and cultured in saline solution. RNA was isolated
at the tadpole stage and subjected to RT-PCR. The expression of to BMP, and these gene responses differ depending
globin, the neural marker nrp-1, and the cement gland marker xag-1 on the cell type. The pathway variegation that can be
were tested. EF-1a is a loading control. generated by the known BMP receptors and Smads is
(D) Dominant-negative OAZ does not inhibit activin signaling. Activin
too limited to account for this diversity of responses.(100 pg) or BMP2 (500 pg) mRNA were injected alone or together
Moreover, based on their DNA-binding properties alone,with ZF1-13 transcripts (5 ng) into the animal pole of two-cell stage
embryos. Animal caps were dissected at the blastula stage and the Smad proteins cannot discriminate among different
harvested at the tadpole stage. The expression of globin, muscle BMP target genes, or even among BMP and TGFb or
actin, and EF-1a was assayed by RT-PCR. activin target genes (Shi et al., 1998). Factors must there-
fore exist that allow the BMP-activated Smads to recog-
nize, in a cell-specific manner, different BMP targetIn ectodermal explants, injection of ZF1-13 or ZF14-
genes. The present identification of OAZ as a Smad30 transcripts induced neural (nrp-1) and cement gland
partner in the recognition of Xvent-2 substantiates this(xag-1) markers (Figure 6C). Coinjection of Smad1 abol-
hypothesis and unexpectedly reveals that a partner ofished the neuralizing effect of these dominant-negative
Smads can be a multifunctional factor involved in otherOAZ constructs, while the induction of globin in re-
sponse to Smad1 overexpression was prevented by pathways as well.
Smad Cofactor in BMP Signaling
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Figure 7. Antagonism between Smads and Olf/EBF as Partners of OAZ
(A) Olf/EBF antagonizes OAZ-dependent Xvent-2 activation. P19 cells were transfected with Xvent-2 reporter (2245/21-luc) and wild-type
hOAZ or the ZF9-19 construct (250 ng/well) together with increasing amount of Olf/EBF (500, 750, and 1000 ng/well). Cells were treated (black
bars) or untreated (open bars) with 1 nM BMP2 for 18 hr prior to luciferase assay.
(B) BMP2 signaling via OAZ, Smad1, and Smad4 antagonizes Olf/EBF function. The pGL-P reporter construct was transfected into P19 cells
with wild-type OAZ (250 ng/well), Olf/EBF (500 ng/well), and Smad1 and Smad4 expression plasmids (1000 ng each/well). Luciferase assay
was performed as described in (A).
(C) A model for the bifunctional role of OAZ. OAZ utilizes different sets of zinc fingers to interact with Smad1-Smad4 (fingers 14±19) and Olf/
EBF (fingers 28±30). The interaction with a specific partner may favor the interaction of OAZ with a distinct DNA sequence through different
sets of fingers: OAZ contacts the Xvent-2 BRE through fingers 9±13 in concert with BMP-activated Smads, and the CCGCCC sequence
through fingers 2±8 in concert with Olf1/EBF. In tissues not expressing Olf1/EBF, the Olf1/EBF-interacting regions may serve other roles
synergistically or antagonistically with BMP Smads.
OAZ as a DNA-Binding Partner and binding of a BMP-induced endogenous Smad com-
plex are also essential for binding and activation by anof BMP-Activated Smads
We chose to focus on Xvent-2 as a target of BMP signal- exogenous OAZ±Smad complex.
The expression pattern of XOAZ in early embryogene-ing because of the pivotal role this gene plays, along
with Xvent-1, in the formation of ventral mesoderm and sis overlaps that of Xvent-1 and Xvent-2. Key evidence
is provided by the use of dominant-negative OAZ con-suppression of neural differentiation (Onichtchouk et al.,
1996; 1998). We have identified a 53 bp Xvent-2 region structs in Xenopus embryo assays. These constructs
reduce the endogenous expression of Xvent-1 andthat has the features of a functional BRE. This BRE
specifically responds to BMP in a Smad1- and Smad4- Xvent-2 at the gastrula stage, cause a partial dorsaliza-
tion of ventral mesoderm at the tadpole stage, and in-dependent manner and in a cell-specific manner.
Xvent-1 and Xvent-2 contain segments of sequence duce neural and cement gland gene markers in ecto-
derm explants. This is fully consistent with a blockade ofidentity within the BRE, including the Smad-binding site
CAGAC and a 39 flanking sequence, TGGAGC. Mutation the ventralizing and antineurogenic functions of Xvent-1
and Xvent-2. The ability of the dominant-negative OAZof either sequence eliminates the BMP2 responsiveness
of the Xvent-2 promoter, suggesting that BMP-activated construct to inhibit induction of the ventral marker globin
by Smad1 is consistent with the involvement of Smad1Smads recognize the Xvent-2 promoter in cooperation
with a unique DNA-binding factor. Using the Xvent-2 in Xvent-2 activation. Their ability to inhibit the effect of
BMP2, but not that of activin in animal caps, demon-BRE to search for proteins that interact with this se-
quence, we have identified OAZ as such a factor. strates pathway specificity. In sum, the evidence sug-
gests that OAZ or a closely related factor of similarOAZ specifically cooperates with BMP-activated
Smads in binding to the Xvent-2 BRE and activating specificity cooperates with Smads to mediate BMP acti-
vation of Xvent expression and the developmentaltranscription. The CAGAC and TGGAGC boxes in the
Xvent-2 BRE that are essential for the BMP response events that result.
Cell
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OAZ Provides Specificity in the BMP Pathway BRE- and Sp1-like sites, respectivelyÐare also differ-
ent. Moreover, the protein- and DNA-binding regionsOAZ provides three levels of specificity in BMP signal-
ing. By being able to cooperate with Smad1 and BMP involved in one pathway are distinct and separate from
those involved in the other.but not Smad2 or TGFb, OAZ provides pathway specific-
ity. By recognizing target genes that contain the appro- As a bifunctional protein, OAZ has the capacity to
coordinate the activities of various signaling pathways.priate BRE, such as Xvent-2, but not others, such as
Tlx2, OAZ provides target gene specificity in BMP-stim- In our reporter assays, Smads and Olf-1/EBF interfere
with each other in their use of OAZ as a transcriptionalulated cells. And by being expressed in some cell types
but not others, OAZ provides cell-type specificity to the partner. Steric hindrance or the involvement of a com-
mon region in both pathways may cause Smads and Olfresponse of OAZ-dependent BMP target genes.
The role of OAZ as a partner of Smads in BMP signal- to be mutually exclusive in their use of OAZ. It will be
of interest to determine whether the ability of BMPsing is likely to extend beyond the regulation of Xvent-1
and Xvent-2. At the tadpole stage, XOAZ is highly ex- to inhibit neurogenesis in olfactory epithelium cultures
(Shou et al., 1999) involves an inhibition of Olf-OAZ coop-pressed in regions of the nervous system that contain
BMP ligands, receptors, and Smads, but no longer de- eration by BMP-activated Smads. However, the impact
of OAZ on Olf-1/EBF-dependent transcription is com-pends on Xvent-1 or Xvent-2. Therefore, OAZ may medi-
ate BMP effects on brain target genes yet to be identi- plex, with both positive and negative effects, depending
on the promoter (Tsai and Reed, 1997; Tsai and Reed,fied. The same applies to the various human fetal and
adult tissues that express OAZ, many of which are 1998). Moreover, the regions of OAZ involved in the Olf-
1/EBF pathway may have other funtions in the largeknown to contain active BMP pathways. In these tissues
OAZ could recruit BMP-activated Smads to promoters number of tissues that express OAZ but not Olf-1/EBF.
Thus, the multifunctional potential of OAZ may extendcontaining the Smad/OAZ consensus BRE. The present
delineation of this BRE may provide clues for the identifi- well beyond that revealed by the present work.
OAZ provides an example of a protein that can usecation of additional gene targets of the BMP-Smad-OAZ
pathway. different sets of fingers for separate signaling pathways.
However, zinc fingers are among the most common
DNA-binding motifs in eukaryotes, and many zinc finger
Modular Structure of OAZ proteins contain multiple copies of this motif (Klug,
In general terms, the function of OAZ in BMP signaling 1999). Therefore, the strategy used by OAZ might also
resembles that of the Fast proteins in activin signaling. be used by other multi±zinc finger proteins to coordinate
Structurally, however, OAZ represents a major departure different signaling pathways during development and
from this class of proteins. OAZ belongs to the family tissue homeostasis.
of KruÈ ppel-like C2H2 zinc finger proteins, whereas the
Fast proteins (Chen et al., 1996; LabbeÂ et al., 1998; Zhou,
Experimental Procedures1998) belong to the winged-helix protein family. The
DNA-binding motifs that characterize these two large
DNA Interaction-Cloning and DNA Interaction Assay in Yeastgene families are very different (Kaufmann and Knochel, A Xenopus oocyte cDNA library in the pGAD10 fusion vector (Clon-
1996; Cook et al., 1999; Turner and Crossley, 1999). tech), which provides an amino-terminal GAL4 fusion transcriptional
With 30 zinc fingers, OAZ is one of the largest mem- activation domain, was transformed into a yeast strain bearing a
tetramerized BRE sequence upstream of the HIS3 reporter genebers of the KruÈ ppel-like zinc finger protein family (Turner
and plated on histidine media. DNA from positive colonies wasand Crossley, 1999). Remarkably, each cluster of fingers
transformed into yeast containing a BRE upstream of lacZ. Fifteenin OAZ has a different protein- or DNA-binding function.
independent clones were identified that bound to both BRE-HIS3Fingers 9 to 13 mediate binding to the BRE, whereas and BRE-lacZ strains. b-galactosidase activity was measured in
fingers 14 to 19 in the next cluster bind to Smads. It solution with o-nitrophenyl-b-D-galactoside as the substrate. Enzy-
was previously shown that fingers 27 to 30 bind Olf-1/ matic activity was calculated from the following equation: 1000(A420/
A600tv) (t 5 time and v 5 volume).EBF and, in that context, fingers 2 to 8 bind Sp1-like
GC-rich DNA sites (Sp1 being a zinc-finger protein itself)
(Tsai and Reed, 1998). The BRE- and Smad-binding re- Plasmid Construction
A human OAZ cDNA missing the first 18 codons (KIAA0760) wasgions of OAZ (fingers 9 to 19) constitute a functional
obtained from the Kazusa DNA Research Institute (Nagase et al.,module that is necessary and sufficient for Smad activa-
1998). A clone containing the amino-terminal end of human OAZtion of the Xvent-2 promoter in response to BMP2.
cDNA (ATCC Clone No. 2019478) was obtained from the EST data-
base and sequenced. Full-length cDNA encoding human OAZ was
constructed by fusing synthesized oligonucleotides encoding theBifunctional Nature of OAZ
first 18 amino acids to the KIAA0760 clone. A Flag epitope tag wasThe present identification of OAZ as a partner of BMP-
introduced at the amino terminus of OAZ by PCR. All the OAZ
activated Smads and its previous identification as a part- deletion constructs were generated by PCR, verified by sequencing,
ner of Olf-1/EBF implicated in olfactory epithelium and and subcloned into the pCS2 vector. ZF-9-13 mutant was generated
by mutating the following amino acid residues to alanine: Asn360,B lymphocyte development (Tsai and Reed, 1997; Tsai
Glu366, Thr392, Glu398, Asp431, Glu437, Thr468, Glu474, Phe514, and Thr520.and Reed, 1998) establish the multifunctional character
The 59 terminus deletion mutants and point mutants of the pVent2-of this protein. In both pathways OAZ assembles a tran-
luc construct were generated by PCR and subcloned into pSO-luc.scriptional complex by binding to a partner protein and
The BRE(2243/2191)x4-luc construct was generated by cloning
to DNA. However, the protein partnersÐthe Smad1- four copies of the BRE sequence upstream of the E1b TATA box in
Smad4 complex and Olf-1/EBF, respectivelyÐare differ- the pE1b-luc vector. GST-Smad1(MH2), Smad2(MH2), and Smad4(MH2)
constructs have been described (Liu et al., 1996).ent in the two cases. The cognate DNA sequencesÐthe
Smad Cofactor in BMP Signaling
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Cell Culture, Transfection, and Reporter Assays TACAAC and ATACATGGGCTCTGATGCGTCC as primers. HPRT
primers were described before (LabbeÂ et al., 1998).Cell lines were maintained in DME supplemented with 10% fetal
bovine serum. P19 and C2C12 or C3H10T1/2 cells were transfected
in six-well plates using LipofectAMINE (GIBCO-BRL) and Transfectin Acknowledgments
(Qiagen), respectively, according to the manufacturer's instructions.
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